Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 3;16(3):e0248042.
doi: 10.1371/journal.pone.0248042. eCollection 2021.

Development of a multiplex Loop-Mediated Isothermal Amplification (LAMP) assay for on-site diagnosis of SARS CoV-2

Affiliations

Development of a multiplex Loop-Mediated Isothermal Amplification (LAMP) assay for on-site diagnosis of SARS CoV-2

Woong Sik Jang et al. PLoS One. .

Abstract

A newly identified coronavirus, designated as severe acute respiratory syndrome coronavirus 2 (SARS CoV-2), has spread rapidly from its epicenter in China to more than 150 countries across six continents. In this study, we have designed three reverse-transcription loop-mediated isothermal amplification (RT-LAMP) primer sets to detect the RNA-dependent RNA polymerase (RdRP), Envelope (E) and Nucleocapsid protein (N) genes of SARS CoV-2. For one tube reaction, the detection limits for five combination SARS CoV-2 LAMP primer sets (RdRP/E, RdRP/N, E/N, RdRP/E/N and RdRP/N/Internal control (actin beta)) were evaluated with a clinical nasopharyngeal swab sample. Among the five combination, the RdRP/E and RdRP/N/IC multiplex LAMP assays showed low detection limits. The sensitivity and specificity of the RT-LAMP assay were evaluated and compared to that of the widely used Allplex™ 2019-nCoV Assay (Seegene, Inc., Seoul, South Korea) and PowerChek™ 2019-nCoV Real-time PCR kit (Kogenebiotech, Seoul, South Korea) for 130 clinical samples from 91 SARS CoV-2 patients and 162 NP specimens from individuals with (72) and without (90) viral respiratory infections. The multiplex RdRP (FAM)/N (CY5)/IC (Hex) RT-LAMP assay showed comparable sensitivities (RdRP: 93.85%, N: 94.62% and RdRP/N: 96.92%) to that of the Allplex™ 2019-nCoV Assay (100%) and superior to those of PowerChek™ 2019-nCoV Real-time PCR kit (RdRP: 92.31%, E: 93.85% and RdRP/E: 95.38%).

PubMed Disclaimer

Conflict of interest statement

No authors have competing interests.

Figures

Fig 1
Fig 1. Limit of detection for the monoplex SARS CoV-2 RT-LAMP assay.
The limit of detection for the monoplex SARS CoV-2 RdRP (A), E (B) and N (C) RT-LAMP assay was tested with synthetic RdRP, E and N plasmid ranging from 108 to 100 copies/μL, respectively. Numbers (1–10) indicated plasmid copy numbers/μL (1.0 × 108–1.0 × 100 copies/μL) and negative control (distilled water (DW) as non-template control).
Fig 2
Fig 2. Limit of detection (LOD) tests of the monoplex and multiplex RT-LAMP assay, Allplex™ 2019-nCoV Assay and PowerChek™ 2019-nCoV Real-time PCR kit for clinical SARS CoV-2 NP sample (range of 10−3–10−7).
(A) Detection limits of monoplex SARS CoV-2 RdRP (left), E (middle) and N (right) LAMP primer sets. (B) Detection limits of the multiplex SARS CoV-2 RdRP/E (upper left), RdRP/N (upper middle), E/N (upper right), RdRP/E/N (lower left) and RdRP/N/IC (lower middle) LAMP primer sets (C) Detection limits of Allplex™ 2019-nCoV assay (Left) and PowerChek™ 2019-nCoV Real-time PCR kit (Right).

Similar articles

Cited by

References

    1. Chan JF-W, Yuan S, Kok K-H, To KK-W, Chu H, Yang J, et al.. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet. 2020;395(10223):514–23. 10.1016/S0140-6736(20)30154-9 - DOI - PMC - PubMed
    1. Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al.. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2020;25(3). Epub 2020/01/30. 10.2807/1560-7917.Es.2020.25.3.2000045 - DOI - PMC - PubMed
    1. Hui DS, E IA, Madani TA, Ntoumi F, Kock R, Dar O, et al.. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020;91:264–6. Epub 2020/01/19. 10.1016/j.ijid.2020.01.009 . - DOI - PMC - PubMed
    1. Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS. J Virol. 2020. Epub 2020/01/31. 10.1128/JVI.00127-20 . - DOI - PMC - PubMed
    1. Wassenaar TM, Zou Y. 2019_nCoV/SARS-CoV-2: rapid classification of betacoronaviruses and identification of Traditional Chinese Medicine as potential origin of zoonotic coronaviruses. Lett Appl Microbiol. 2020. Epub 2020/02/16. 10.1111/lam.13285 . - DOI - PMC - PubMed

Publication types

MeSH terms

Supplementary concepts